These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 8137961)

  • 61. Effect of estrogen plus progestin on global cognitive function in postmenopausal women: the Women's Health Initiative Memory Study: a randomized controlled trial.
    Rapp SR; Espeland MA; Shumaker SA; Henderson VW; Brunner RL; Manson JE; Gass ML; Stefanick ML; Lane DS; Hays J; Johnson KC; Coker LH; Dailey M; Bowen D;
    JAMA; 2003 May; 289(20):2663-72. PubMed ID: 12771113
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Regression of Polycystic Ovaries by Estrogen Therapy.
    Gambrell RD
    Obstet Gynecol; 1976 May; 47(5):569-74. PubMed ID: 131262
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Gonadotropin-releasing hormone agonists and estrogen-progestogen replacement therapy.
    Barbieri RL
    Am J Obstet Gynecol; 1990 Feb; 162(2):593-5. PubMed ID: 2137979
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Efficacy of myo-inositol in the treatment of cutaneous disorders in young women with polycystic ovary syndrome.
    Zacchè MM; Caputo L; Filippis S; Zacchè G; Dindelli M; Ferrari A
    Gynecol Endocrinol; 2009 Aug; 25(8):508-13. PubMed ID: 19551544
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Oral contraceptives increase insulin-like growth factor binding protein-1 concentration in women with polycystic ovarian disease.
    Suikkari AM; Tiitinen A; Stenman UH; Seppälä M; Laatikainen T
    Fertil Steril; 1991 May; 55(5):895-9. PubMed ID: 1708731
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Polycystic ovaries in Hirsute women with normal menses.
    Carmina E; Lobo RA
    Am J Med; 2001 Dec; 111(8):602-6. PubMed ID: 11755502
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Assessing the adequacy of gonadotropin-releasing hormone agonist leuprolide to trigger oocyte maturation and management of inadequate response.
    Chang FE; Beall SA; Cox JM; Richter KS; DeCherney AH; Levy MJ
    Fertil Steril; 2016 Oct; 106(5):1093-1100.e3. PubMed ID: 27341988
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial.
    Gregoriou O; Konidaris S; Vitoratos N; Papadias C; Papoulias I; Chryssicopoulos A
    Int J Fertil Womens Med; 1997; 42(6):406-11. PubMed ID: 9459084
    [TBL] [Abstract][Full Text] [Related]  

  • 69. [Treatment of hirsutism in micropolycystic ovary syndrome with estrogens and sequential prostagen].
    Porcile A; Martínez E
    Rev Chil Obstet Ginecol; 1982; 47(1):8-17. PubMed ID: 6927152
    [No Abstract]   [Full Text] [Related]  

  • 70. Spironolactone in combination drug therapy for unresponsive hirsutism.
    Pittaway DE; Maxson WS; Wentz AC
    Fertil Steril; 1985 Jun; 43(6):878-82. PubMed ID: 3158552
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Role of the combination spironolactone-norgestimate-estrogen in Hirsute women with polycystic ovary syndrome.
    Hagag P; Steinschneider M; Weiss M
    J Reprod Med; 2014; 59(9-10):455-63. PubMed ID: 25330687
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Insulin resistance improves in hyperandrogenic women treated with Lupron.
    Elkind-Hirsch KE; Valdes CT; Malinak LR
    Fertil Steril; 1993 Oct; 60(4):634-41. PubMed ID: 8405516
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Prospective randomized study comparing the long-acting gonadotropin-releasing hormone agonist triptorelin, flutamide, and cyproterone acetate, used in combination with an oral contraceptive, in the treatment of hirsutism.
    Pazos F; Escobar-Morreale HF; Balsa J; Sancho JM; Varela C
    Fertil Steril; 1999 Jan; 71(1):122-8. PubMed ID: 9935128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Hirsutism in women. Effective therapy that is safe for long-term use.
    Bergfeld WF
    Postgrad Med; 2000 Jun; 107(7):93-4, 99-104. PubMed ID: 10887449
    [TBL] [Abstract][Full Text] [Related]  

  • 75. [Hirsutism].
    van Zuuren EJ; Pijl H
    Ned Tijdschr Geneeskd; 2007 Oct; 151(42):2313-8. PubMed ID: 18064932
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Chronic treatment regimens for hirsutism in women: effect on blood production rates of testosterone and on hair growth.
    Casey JH
    Clin Endocrinol (Oxf); 1975 May; 4(3):313-25. PubMed ID: 125164
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Hirsutism in the adolescent female.
    Bailey-Pridham DD; Sanfilippo JS
    Pediatr Clin North Am; 1989 Jun; 36(3):581-99. PubMed ID: 2660088
    [TBL] [Abstract][Full Text] [Related]  

  • 78. New treatments of hyperandrogenism and hirsutism.
    Hock DL; Seifer DB
    Obstet Gynecol Clin North Am; 2000 Sep; 27(3):567-81, vi-vii. PubMed ID: 10958004
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Hair growth in a patient with hirsutism: poor response to ovarian suppression.
    Biggs JS
    Aust N Z J Obstet Gynaecol; 1973 Nov; 13(4):246-9. PubMed ID: 4532547
    [No Abstract]   [Full Text] [Related]  

  • 80. Pubarche induction with testosterone treatment in women with panhypopituitarism.
    Padova G; Finocchiaro C; Briguglia G; Magro A; Tita P; Pezzino V
    Fertil Steril; 1996 Feb; 65(2):437-9. PubMed ID: 8566275
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.